共 12 条
[1]
Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system. Cauliez B,Guignery S,Marinier S,et al. Annals of Clinical Biochemistry . 2008
[2]
Application of NT-proBNP and BNP measurements in cardiac care:a more discerning marker for the detection and evalution of heart failure. Seino Y,Ogawa A,Yanmashita Tet al. European Journal of Heart Failure . 2004
[3]
Aminoterminal pro type B na-triuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M,Wichter T,Schmid C. The Journal of Heart and Lung Transplantation . 2004
[4]
Heart[P]. 英国专利:GB0418877D0,2004-09-29
[5]
Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival COPERNICUS) trial. Hartmann,F,Packer,M,Coats,AJ. Circulation . 2004
[6]
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide ( N-BNP )concentrations. Troughton RW,Frampton CM,Yandle TG,et al. The Lancet . 2000
[7]
Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Yeo,KT,Wu,AH,Apple,FS,Kroll,MH,Christenson,RH,Lewandrowski,KB,Sedor,FA,Butch,AW. Clinica Chimica Acta . 2003
[8]
Comparison of brain natriuretic peptide(BNP)and amio-terminal proBNP for early diagnosis of heart failure. Emdin M,Passino C,Prontera C,et al. Clinical Chemistry . 2007
[9]
Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Grewal J,McKelvie RS,Persson H,et al. The American Journal of Cardiology . 2008
[10]
NT-proBNPand the diagnosis of heart failure:a pooled analysis of threeEuropean epidemiological studies. McDonagh TA,Holmer S,Raymond I,et al. European Journal of Heart Failure . 2004